Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.70 |
| ▸ | PARP1 | P09874 | 1/20 | 0.58 |
| ▸ | PRKCI | P41743 | 2/20 | 0.56 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.53 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | AHR | P35869 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30901792 | 1.00 | NAPRT (0.70) | NAPRTPARP1PRKCIMKNK1MKNK2 | |
| Hydrochloric Acid SCHEMBL11788163 | 0.98 | NAPRT (0.68) | NAPRTPARP1PRKCIMKNK1MKNK2 | |
| 2-Aminopyridine SCHEMBL15270616 | 0.89 | NAPRT (0.58) | NAPRTPARP1PRKCIMKNK1MKNK2 | |
| Propionic Acid SCHEMBL27888844 | 0.88 | NAPRT (0.61) | NAPRTPARP1PRKCIMKNK1MKNK2 | |
| Carbamic Acid SCHEMBL27881895 | 0.85 | NAPRT (0.96) | NAPRTPARP1PRKCIMKNK1MKNK2 | |
| SCHEMBL8198020 | 0.84 | NAPRT (0.73) | NAPRTPARP1PRKCIMKNK1MKNK2 | |
| SCHEMBL28253352 | 0.83 | MKNK1 (0.58) | NAPRTPARP1PRKCIMKNK1MKNK2 | |
| SCHEMBL31230208 | 0.83 | MKNK1 (0.58) | NAPRTPARP1PRKCIMKNK1MKNK2 | |
| SCHEMBL11098869 | 0.83 | NAPRT (0.70) | NAPRTPARP1PRKCIMKNK1MKNK2 | |
| SCHEMBL29530139 | 0.83 | NAPRT (1.00) | NAPRTPRKCIKDM4EALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 525 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119776854-A | Electrochemical preparation method of adiponitrile | 万华化学集团股份有限公司 | 2025-04-08 | — | — | CN | claimed |
| CN-119384143-A | Preparation method of perovskite solar cell based on nicotinamide derivative material passivation | 南开大学 | 2025-01-28 | — | — | CN | claimed |
| WO-2024148139-A2 | METABOLITE-BASED PARTICLES AND COMPOSITIONS THEREOF FOR PREVENTING AND TREATING NEUROLOGICAL DISEASES AND DISORDERS | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2024-07-11 | — | — | WO | claimed |
| CN-114807988-B | Electrode material for synthesizing dialdehyde starch by using electrolytic starch, preparation method of electrode material and electrochemical preparation method of dialdehyde starch | 万华化学集团股份有限公司 | 2024-06-25 | — | — | CN | claimed |
| EP-3670490-B1 | METHOD OF PURIFYING PINE CHEMICAL COMPOSITIONS FROM ALDEHYDES | KRATON POLYMERS LLC (US) | 2023-01-18 | — | — | EP | claimed |
| CN-111004284-B | Synthesis method and application of polysubstituted 2-aminopyridine derivative | 重庆大学 | 2022-08-05 | — | — | CN | claimed |
| CN-114807988-A | Electrode material for synthesizing dialdehyde starch by electrolyzing starch and preparation method thereof and electrochemical preparation method of dialdehyde starch | 万华化学集团股份有限公司 | 2022-07-29 | — | — | CN | claimed |
| EP-3670490-A1 | METHOD OF PURIFYING PINE CHEMICAL COMPOSITIONS FROM ALDEHYDES | Kraton Polymers LLC (US) | 2020-06-24 | — | — | EP | claimed |
| US-20200165191-A1 | Method of Purifying Pine Chemical Compositions from Aldehydes | KRATON POLYMERS LLC (US) | 2020-05-28 | — | — | US | claimed |
| CN-111004284-A | Synthesis method and application of polysubstituted 2-aminopyridine derivative | 重庆大学 | 2020-04-14 | — | — | CN | claimed |
| CN-101765425-A | Use of benzamide derivatives for the treatment of CNS disorders | HOFFMANN LA ROCHE | 2010-06-30 | — | — | CN | claimed |
| US-7547713-B2 | O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives | GU LIANQUAN | 2009-06-16 | — | — | US | claimed |
| US-20080167375-A1 | TREATMENT OF CUTANEOUS NEUROGENIC INFLAMMATION | ASTION PHARMA A/S | 2008-07-10 | — | — | US | claimed |
| WO-2007140791-A1 | TREATMENT OF CUTANEOUS NEUROGENIC INFLAMMATION | ASTION PHARMA A/S (DK) | 2007-12-13 | — | — | WO | claimed |
| EP-1864657-A1 | Treatment of cutaneous neurogenic inflammation | Astion Pharma A/S (DK) | 2007-12-12 | — | — | EP | claimed |
| US-20060111405-A1 | O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives | GU LIANQUAN | 2006-05-25 | — | — | US | claimed |
| EP-1560589-A1 | NOVEL COMPLEXES OF FATTY ACID ESTERS OF POLYHYDROXYALKANES AND PYRIDINE CARBOXY DERIVATIVES | Astion Dermatology A/S (DK) | 2005-08-10 | — | — | EP | claimed |
| US-20040192744-A1 | N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents | HAAG RAINER (DE) | 2004-09-30 | — | — | US | claimed |
| WO-2004000333-A1 | NOVEL COMPLEXES OF FATTY ACID ESTERS OF POLYHYDROXYALKANES AND PYRIDINE CARBOXY DERIVATIVES | ASTION DERMATOLOGY A/S (DK) | 2003-12-31 | — | — | WO | claimed |
| US-20030139404-A1 | N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents | HOFFMANN-LA ROCHE INC. | 2003-07-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060111405-A1 | O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives | PTGS2, PTGES2, PTGES | NAPRT 262/4885PARP1 368/4885PRKCI 2541/4885 |
| US-20040192744-A1 | N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents | NAT1, CYP1A1, UGT1A1 | NAPRT 447/4885PARP1 710/4885PRKCI 4606/4885 |
| US-20080167375-A1 | TREATMENT OF CUTANEOUS NEUROGENIC INFLAMMATION | CUTA, SCD, ALOX15B | NAPRT 805/4885PARP1 3795/4885PRKCI 2405/4885 |
| US-20030139404-A1 | N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents | NAT1, CYP1A1, UGT1A1 | NAPRT 447/4885PARP1 710/4885PRKCI 4606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.